Cart

0

Stocks

“Up 71%, Is Novavax Stock Still a Strong Buy?”

“Yesterday, next-generation vaccine maker Novavax (NASDAQ:NVAX) saw its shares jump by an astounding 71% on nearly 24 times the average daily volume. Investors bid up this small-cap biotech stock in response to the spread of a deadly respiratory virus (a type of coronavirus) from China… Continue Reading…